STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
30.07.2014 18:14
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Correction of the release dated April 30, 2014
Hermann Leistner, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that his share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 25.79% on this date (3,035,456
voting rights). Of these, 9.69% (1,140,000 voting rights) are attributable
to him via Herdor GmbH & Co. KG and Herdor Beteiligungs GmbH pursuant to
sec. 22 para 1 sentence 1 no. 1 of the German Securities Trading Act
(WpHG). A further 15.72% (1,850,000 voting rights) are attributable to him
via Tanja van Dinter, Bettina Siegle, and Ralf Leistner pursuant to sec. 22
para 2 of the German Securities Trading Act (WpHG).
Correction of the release dated April 30, 2014
Doris Leistner, Germany, notified us pursuant to sec. 21 para 1 of the
German Securities Trading Act (WpHG) that her share of the voting rights in
STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 15,
20 and 25% on April 27, 2014 and amounted to 25.74% on this date (3,030,235
voting rights). Of these, 9.69% (1,140,000 voting rights) are attributable
to her via Herdor GmbH & Co. KG and Herdor Beteiligungs GmbH pursuant to
sec. 22 para 1 sentence 1 no. 1 of the German Securities Trading Act
(WpHG). A further 15.72% (1,850,000 voting rights) are attributable to her
via Tanja van Dinter, Bettina Siegle, and Ralf Leistner pursuant to sec. 22
para 2 of the German Securities Trading Act (WpHG).
Correction of the release dated April 30, 2014 and May 7, 2014
Herdor Beteiligungs GmbH, Unterschleissheim, Germany, notified us pursuant
to sec. 21 para 1 of the German Securities Trading Act (WpHG) that its
share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
exceeded the thresholds of 10, 15, 20 and 25% on April 27, 2014 and
amounted to 25.40% on this date (2,990,000 voting rights). Of these, 9.69%
(1,140,000 voting rights) are attributable to it via Herdor GmbH & Co. KG
pursuant to sec. 22 para 1 sentence 1 no. 1 of the German Securities
Trading Act (WpHG). A further 15.72% (1,850,000 voting rights) are
attributable to it via Tanja van Dinter, Bettina Siegle, and Ralf Leistner
pursuant to sec. 22 para 2 of the German Securities Trading Act (WpHG).
30.07.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back